Document Detail


Expressive disclosure to improve well-being in patients with amyotrophic lateral sclerosis: a randomised, controlled trial.
MedLine Citation:
PMID:  23289543     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Amyotrophic lateral sclerosis (ALS) is a terminal neurological disease associated with progressive paralysis, loss of communicative ability and functional decline. Expressive disclosure may help people with ALS, particularly those who are emotionally or socially inhibited, meet psychological challenges associated with the disease. People with ALS (N = 48) were randomised to expressive disclosure about their disease or no disclosure. Psychological well-being (affect, depression and quality of life) was assessed pre-intervention and also three and six months later. Results of multi-level models indicated that the group that disclosed thoughts and feelings about ALS had higher well-being than the control group at three months post-intervention, but not six months. Ambivalence over emotional expression (AEE) moderated three-month post-intervention well-being. Those low in AEE had higher well-being than those high in AEE regardless of condition. Those high in AEE, who disclosed, had increased well-being from pre-intervention, whereas controls had decreased well-being from pre-intervention. Expressive disclosure may be helpful for people with ALS, but only those who have difficulty expressing emotions. In addition, the intervention had only temporary effects; the dynamic challenges of ALS progression may mean that the effect of processing thoughts and feelings about the disease in one stage may not generalise to later stages.
Authors:
Alyssa J Averill; Edward J Kasarskis; Suzanne C Segerstrom
Related Documents :
8839743 - Initial treatment of preterm infants--continuous positive airway pressure or ventilation?
23992043 - Effects and safety of lanthanum carbonate in end stage renal disease patients with hype...
18712943 - Effectiveness of foot orthoses for treatment and prevention of lower limb injuries : a ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2013-01-07
Journal Detail:
Title:  Psychology & health     Volume:  28     ISSN:  1476-8321     ISO Abbreviation:  Psychol Health     Publication Date:  2013  
Date Detail:
Created Date:  2013-05-23     Completed Date:  2013-08-07     Revised Date:  2013-12-05    
Medline Journal Info:
Nlm Unique ID:  8807983     Medline TA:  Psychol Health     Country:  England    
Other Details:
Languages:  eng     Pagination:  701-13     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Amyotrophic Lateral Sclerosis / psychology*
Attitude to Health*
Emotions*
Female
Follow-Up Studies
Humans
Life Change Events
Male
Middle Aged
Quality of Life / psychology*
Self Disclosure*
Speech
Stress, Psychological
Writing
Grant Support
ID/Acronym/Agency:
K02-AG033629/AG/NIA NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paclitaxel drug delivery systems.
Next Document:  Development of a Novel Native Nano-Electrospray Mass Spectrometry Method for Determination of Drug-t...